期刊文献+

不同类型膀胱癌组织中环氧化酶-2的表达及意义 被引量:3

Expression of cyclooxygenase-2 in various kinds of bladder cancer tissues and its significance
原文传递
导出
摘要 目的探讨环氧化酶-2(COX-2)在不同类型膀胱癌组织中的表达及临床意义。方法应用免疫组化染色方法检测52例膀胱移行细胞癌组织(其中T_1 18例、T_2 14例、T_1 14例、T_4 6例,G_1 13例、G_2 25例、G_3 14例,肿瘤单发37例、多发15例)、20例膀胱腺癌组织、10例膀胱鳞状细胞癌组织及17例正常膀胱黏膜组织中COX-2蛋白表达情况,根据染色阳性细胞所占比例,分为(-)、(+)、(++)、(+++)4个等级,用等级资料x^2检验进行统计学分析。结果82例肿瘤组织COX-2蛋白表达率(82.9%,68/82)高于正常黏膜(23.5%,4/17)(P<0.05),不同类型肿瘤COX-2蛋白表达率也有差别,鳞状细胞癌最强(100%,10/10),腺癌次之(90.0%,18/20),移行细胞癌相对较弱(76.9%,40/52)(P<0.05);在52例移行细胞癌标本中,COX-2表达率与肿瘤分级、分期相关(P<0.05)。结论COX-2在不同类型膀胱癌组织中呈高表达,在鳞状细胞癌表达最强,可能成为膀胱癌化学预防的一个靶点。 Objective To investigate the expression of cyclooxygenase-2 (COX-2) in various kinds of bladder cancer tissues,and to understand its clinical significance. Methods Immunohistoehemistry was used to assess the expression of COX-2 in 52 cases of bladder transitional cell carcinoma tissues ( including T1 stage tumor in 18 cases,T2 in 14,T3 in 14 and T4 in 6:G1 tumor in 13 cases,G2 in 25 and G3 in 14;single tumor in 37 cases and muhiple tumors in 15 ) ,20 cases of bladder adenocarcinoma tissues, 10 cases of bladder squamous cell carcinoma tissues and 17 cases of normal bladder tissues. Based on the proportion of positive cells by staining, the expression of COX-2 protein was classified into 4 grades, ie, ( - ) , ( + ) , ( + + ), and ( + + + ) : and statistical analysis was performed on them. Results COX-2 expression rate in bladder cancer tissues was significantly higher than that in normal bladder tissues ( P 〈 0.05). Specifically, its expression was strong in squamous cell carcinoma, moderate in adenocarcinoma and weak in transitional cell carcinoma, respectively ( P 〈 0.05 ). The expression of COX-2 protein in the 52 cases of transitional cell carcinoma was correlated with the stage and grade of the cancer (P 〈 0.05). Conclusions COX-2 is overexpressed in various kinds of bladder cancers, and most strongly expressed in squamous cell carcinoma, thus it may become a useful target of chemoprevention of bladder cancers.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2006年第12期830-832,共3页 Chinese Journal of Urology
关键词 膀胱肿瘤 环氧化酶-2 基因 Bladder neoplasms Carcinoma Cyclooxygenase-2 Genes
  • 相关文献

参考文献12

  • 1Subbaramaiah K,Zakim D,Weksler BB,et al.Inhibition of cyclooxygenase:a novel approach to cancer prevention.Proc Soc Exp Bio Med,1997,216:201-210.
  • 2Thun MJ,Henley SJ,Patrono C.Nonsteroidal Anti-inflammatory Drugs as anticancer agents:mechanistic,pharmacyologic,and clinical issues.J Natl Cancer Inst,2002,94:252-266.
  • 3Komhoff M,Guan Y,Shappell HW,et al.Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.Am J Pathol,2000,157:29-35.
  • 4Ristimaki A,Nieminen O,Saukkonen K,et al.Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.Am J Pathol,2001,158:849-853.
  • 5Sweeney CJ,Marshall MS,Barnard DS,et al.Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissue.Cancer Detect Prev,2002,26:238-244.
  • 6Gee JR,Montoya RG,Khaled HM,et al.Cytokeratin 20,AN43,PGDH,and COX-2 expression in transitional and squamous cell carcinoma of the bladder.Urol Oncol,2003,21:266-270.
  • 7任亮,侯树坤,何凌峰,叶海云,管考鹏.膀胱移行细胞癌组织中环氧化酶-2的表达及其意义[J].中华外科杂志,2004,42(18):1104-1107. 被引量:6
  • 8Harris SG,Padilla J,Koumas L,et al.Prostaglandins as modulators of immunity.Trends Immunol,2002,23:144-150.
  • 9Diamantopoulou K,Lazaris A,Mylona E,et al.Cyclooxygenase-2 protein expression in relation to apoptotic potential and its prognostic significance in bladder urothelial carcinoma.Anticancer Res,2005,25:4543-4549.
  • 10Lagergren J,Bergstrom R,Lindgren A,et al.Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.N Engl J Med,1999,340:825-831.

二级参考文献13

  • 1Subbaramaiah K, Zakim D, Weksler BB, et al. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Pr℃ SoC Exp Bio Med, 1997, 216:201-210.
  • 2Thun MJ, Henley SJ, Patrono C. Nonsteroidal Anti-inflammatory Drugs as anticancer agents: mechanistic, pharmacyologic, and clinical issues. J Natl Cancer Inst, 2002, 94:252-266.
  • 3Mohammed SI, Knapp DW, Bostwick DG, et al. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res, 1999, 59:5647-5650.
  • 4Komhoff M, Guan Y, Shappell HW, et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol, 2000, 157:29-35.
  • 5Shirahama T. Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin Cancer Res, 2000, 6:2424-2430.
  • 6Ristimaki A, Nieminen O, Saukkonen K, et al. Expression of Cyclooxygenase-2 in Human Transitional Cell Carcinoma of the Urinary Bladder. Am J Pathol, 2001, 158:849-853.
  • 7Badawi AF. The role of prostaglandin synthesis in prostate cancer. BJU Int, 2000, 85:451-462.
  • 8Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res, 1992, 52:5575-5589.
  • 9Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 1995, 83:493-501.
  • 10Sheng H, Shoa J, Morrow JD, et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res, 1998, 58:362-366.

共引文献5

同被引文献32

  • 1任亮,侯树坤,何凌峰,叶海云,管考鹏.膀胱移行细胞癌组织中环氧化酶-2的表达及其意义[J].中华外科杂志,2004,42(18):1104-1107. 被引量:6
  • 2张雪梅,缪小平,谭文,孙瞳,郭永丽,赵丹,林东昕.环氧化酶2启动子区遗传变异及其与胃癌发病风险的关系[J].中国医学科学院学报,2006,28(2):119-123. 被引量:13
  • 3Cox DG, Buring J, Hankinson SE, et al. A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study. Breast Cancer Res, 2007, 9:R3.
  • 4Lee KH, Kim HS, EI-Sohemy A, et al. Cyclooxygenase-2 genotype and rheumatoid arthritis. J Rheumatol, 2006, 33: 1231-1234.
  • 5Zhang XM, Miao XP, Tan W, et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology, 2005, 129: 565-576. :
  • 6Hu Z, Miao X, Ma H, et al. A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer,2005, 48: 11-17.
  • 7FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med, 2001, 345 : 433-442.
  • 8Fritsche E, Baek SJ, King LM, et al. Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol ExpTher, 2001, 299:468-476.
  • 9Szezeklik W, Sanak M, Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol, 2004, 114: 248- 253.
  • 10Campa D, Zienolddiny S, Maggini V, et al. Association of a common polymorphism in the cyclooxygenase2 gene with risk of non-small cell lung cancer. Carcinogenesis, 2004, 25: 229- 235.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部